Prescribing oseltamivir (Tamiflu)

18 December 2025

GPs can now prescribe oseltamivir on the NHS at any time of year for eligible patients (no longer restricted to “flu in circulation” periods).

Prescribing essentials:

Prescribe for patients in clinical at-risk groups or those at risk of severe illness/complications from influenza.
Prescription must be endorsed ‘SLS’ (Selected List Scheme).
Follow UKHSA guidance for treatment (within 48h of symptom onset) and post-exposure prophylaxis (within 48h of exposure).
 
At-risk groups include:

  • Chronic respiratory, cardiac, renal, hepatic, or neurological disease
  • Diabetes mellitus
  • Severe immunosuppression
  • Age over 65 years
  • Pregnancy (including up to 2 weeks post-partum)
  • Children under 6 months of age
  • Morbid obesity (BMI ≥40)

References:

UKHSA: Influenza treatment and prophylaxis using anti-viral agents 
 

Accessibility tools

Return to header